Skip to content
healthcare.dev
Get a free key

Myrbetriq

NDC 0469-5020, mirabegron, granule, for suspension, extended release, from Astellas Pharma US, Inc..

Product NDC
0469-5020
Status
Listed
Labeler
Astellas Pharma US, Inc.
Dosage form
GRANULE, FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213801
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0469-5020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON8 mg/mL

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0469-5020-99004695020991 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ba9e9e15-e666-4c56-9271-2e24739cfa2d

  • NADAC price for package 00469502099

    GET /v1/drugs/nadac/00469502099

Use it

Look up 0469-5020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0469-5020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0469-5020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.